GRHPR
protein-codingglyoxylate and hydroxypyruvate reductase
Gene summary
This gene encodes an enzyme with hydroxypyruvate reductase, glyoxylate reductase, and D-glycerate dehydrogenase enzymatic activities. The enzyme has widespread tissue expression and has a role in metabolism. Type II hyperoxaluria is caused by mutations in this gene. [provided by RefSeq, Jul 2008]
- GLXR
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~14.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0009824
Submitter: Natera
Inheritance Pattern: AR
Disease ID:MONDO:0009824
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0009824
Submitter: Myriad Women's Health
Inheritance Pattern: AR
Disease ID:MONDO:0009824
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0009824
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0009824
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Renal
Intervention: Renal
Rationale: Fluid intake and medical management (eg, orthophosphate, potassium citrate, magnesium) to prevent calcium oxalate crystallization can be effective; Temporary dialysis for ESRD, followed by transplantation may be required; Surveillance of renal function and related parameters may be effective; Dehydration and excessive intake of oxalate-rich foods should be avoided
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to GRHPR variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_012203.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | 153 | 3 | 161 | ||
| missense | 4 | 23 | 115 | 15 | 157 | |
| nonsense | 11 | 10 | 21 | |||
| start loss | 1 | 2 | 3 | |||
| frameshift | 40 | 50 | 5 | 95 | ||
| splice donor/acceptor (+/-2bp) | 7 | 28 | 1 | 36 | ||
| Total | 63 | 113 | 126 | 168 | 3 | 473 |
Highest pathogenic variant AF is 0.0004965083
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_036335.1 | 9 | MANE Select | |
| Ensembl | ENSP00000313432.6 | 9 | MANE Select | |
| Ensembl | ENSP00000432021.1 | 2 | Standard | |
| Ensembl | ENSP00000475569.1 | 9 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Pyruvate metabolism - Homo sapiens (human)
- Glycine, serine and threonine metabolism - Homo sapiens (human)
- Glyoxylate and dicarboxylate metabolism - Homo sapiens (human)
- Pyruvate Dehydrogenase Complex Deficiency
- Primary hyperoxaluria II, PH2
Biological Process
- excretion
- cellular nitrogen compound metabolic process
- dicarboxylic acid metabolic process
- glyoxylate metabolic process
- protein complex oligomerization
Molecular Function
- glycerate dehydrogenase activity
- oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
- hydroxypyruvate reductase activity
- glyoxylate reductase (NADP) activity
- carboxylic acid binding
Cellular Component
- cytoplasm
- peroxisomal matrix
- cytosol
- extracellular exosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000318158
- Coding exons
- 9
- Length
- 14325
- Individuals with no LoFs
- 125606
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 142
- Defined
- 125748
- p
- 0.000565
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.739 | 169 | 198 | 0.852 | 0.0000121 | 2104 |
| Missense (PolyPhen) | 53 | 68.075 | 0.77856 | 724 | ||
| Synonymous | -0.434 | 92 | 86.9 | 1.06 | 0.00000586 | 690 |
| Loss of Function | 1.06 | 12 | 16.7 | 0.719 | 8.91e-7 | 181 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00012 | 0.00012 | rare |
| Latino/Admixed American | 0.00029 | 0.00029 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00060 | 0.00060 | rare |
| Finnish | 0.00083 | 0.00083 | rare |
| European (Non-Finnish) | 0.00074 | 0.00072 | rare |
| South Asian | 0.00059 | 0.00056 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Enzyme with hydroxy-pyruvate reductase, glyoxylate reductase and D-glycerate dehydrogenase enzymatic activities. Reduces hydroxypyruvate to D-glycerate, glyoxylate to glycolate oxidizes D-glycerate to hydroxypyruvate.;
Intolerance Scores
- LoFtool
- 0.332
- RVIS EVS
- -0.11
- RVIS percentile EVS
- 45.36
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.955
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |